Clinical Trial Update: A Study to Assess the Pharmacokinetics, Pharmacodynamics of ASP1941 in Diabetes Mellitus Patients With Renal Impairment [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetics and pharmacodynamics study of ASP1941 in patients with Type 2 diabetes mellitus and renal impairment has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ASP1941

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED